VS

Vikas Sharma

Active Director Director DIN 06861155
DIN 06861155 First appointment May 2014 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since May 2014
Shareholding value •••• Premium profile

About Vikas Sharma

Data last updated:

Vikas Sharma is a Director at Bill Cure Pharma Private Limited (since 2014). The company operates in Pharma. Bill Cure Pharma Private Limited reported revenue of ₹24.4 Lakh (FY 2024).

DIN 06861155
Primary Designation Director
Industry Pharma
First Appointment 30 May 2014
Oldest Company Age 12 yrs
Largest company Bill Cure Pharma Private Limited · ₹24.4 Lakh (FY 2024)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Bill Cure Pharma Private Limited U51397HP2014PTC000701
Director30 May 20142014₹24.4 Lakh (FY 2024)Active

Board colleagues of Vikas Sharma

NameDINCompanyDesignation
Manu Sharma06861107Bill Cure Pharma Private LimitedDirector

Directorship timeline

Open interactive timeline →
Bill Cure Pharma Private Limited
Premium access

Shareholding and investment profile for Vikas Sharma

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Vikas Sharma

Vikas Sharma currently holds 1 directorship: Bill Cure Pharma Private Limited (Director, since 30 May 2014, revenue ₹24.4 Lakh (FY 2024)).

Vikas Sharma was first appointed on 30 May 2014 as Director at Bill Cure Pharma Private Limited.

The current boards of Vikas Sharma's companies include Manu Sharma (Bill Cure Pharma Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available